the efficacy and safety of tobramycin ( tob ) administration at 90 mg twice a day ( 90 mg group ) to patients with respiratory tract infections ( rti ) were objectively investigated by means of a well-controlled comparative study .
C0040341
tobramycin
C0035243
respiratory tract infections